News & Perspective

Nov 15, 2012

Nov 15, 2012

Senate committee raises more meningitis outbreak questions

(CIDRAP News) – A Senate committee hearing today on the fungal meningitis outbreak covered some of the same ground as yesterday's House hearing but aired the views of compounding pharmacy industry groups and provided a strong example for strengthening the nation's public health infrastructure.

Nov 14, 2012

Nov 14, 2012

House committee grills FDA over fungal meningitis outbreak

(CIDRAP News) – The first congressional hearing today on the fungal meningitis outbreak linked to tainted steroids was marked by tough questions for regulators, political wrangling, and an appearance by the owner of the compounding pharmacy that produced the drugs, but he declined to testify.

Nov 13, 2012

Nov 13, 2012

Virginia doctors note difficult course for fungal meningitis patients

(CIDRAP News) – Clinicians at a Virginia hospital that screened 172 patients who were exposed to contaminated injectable steroids provided an early snapshot yesterday of patients' clinical courses and more evidence that the organism is invasive, putting patients at risk for strokes.

Nov 07, 2012

Nov 07, 2012

Meningitis outbreak investigators say quick work paid off

(CIDRAP News) – A public health investigation into an unusual fungal meningitis death in Tennessee quickly uncovered other related cases and expedited detection and treatment that probably saved lives, while drawing national attention to the problem, according to a report yesterday from some of the state officials who worked on the probe.

Nov 05, 2012

Nov 05, 2012

Meningitis outbreak toll rises as complications surface

(CIDRAP News) – Fifteen more infections and one more death have been reported in a multistate fungal meningitis outbreak, according to federal health officials, and reports are starting to surface about serious complications in some patients.

Nov 02, 2012

Nov 02, 2012

Bacteria found in two drugs as meningitis outbreak tops 400

(CIDRAP News) – Tests by federal health officials have detected bacterial contamination in two products from the Massachusetts compounding pharmacy linked to a multistate fungal meningitis outbreak caused by tainted steroid drugs, a finding that amplifies worries about the sterility of the company's products.

Nov 01, 2012

Nov 01, 2012

Fungal meningitis outbreak grows to 386 cases

(CIDRAP News) – Nine more patients have been sickened in a multistate fungal meningitis outbreak linked to a Massachusetts company's tainted steroid injections, boosting the total so far to 386, the US Centers for Disease Control and Prevention (CDC) said today.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»